PRPH Relative Valuation
PRPH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PRPH is overvalued; if below, it's undervalued.
Historical Valuation
Prophase Labs Inc (PRPH) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.05 is considered Undervalued compared with the five-year average of 6.56. The fair price of Prophase Labs Inc (PRPH) is between 1.25 to 9.17 according to relative valuation methord. Compared to the current price of 0.20 USD , Prophase Labs Inc is Undervalued By 83.96%.
Relative Value
Fair Zone
1.25-9.17
Current Price：0.20
83.96%
Undervalued
0.00
PE
1Y
3Y
5Y
0.00
EV/EBITDA
Prophase Labs Inc. (PRPH) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 1.47. The thresholds are as follows: Strongly Undervalued below -42.86, Undervalued between -42.86 and -20.69, Fairly Valued between 23.63 and -20.69, Overvalued between 23.63 and 45.80, and Strongly Overvalued above 45.80. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.
-3.03
EV/EBIT
Prophase Labs Inc. (PRPH) has a current EV/EBIT of -3.03. The 5-year average EV/EBIT is -1.16. The thresholds are as follows: Strongly Undervalued below -29.20, Undervalued between -29.20 and -15.18, Fairly Valued between 12.86 and -15.18, Overvalued between 12.86 and 26.88, and Strongly Overvalued above 26.88. The current Forward EV/EBIT of -3.03 falls within the Historic Trend Line -Fairly Valued range.
0.05
PS
Prophase Labs Inc. (PRPH) has a current PS of 0.05. The 5-year average PS is 1.72. The thresholds are as follows: Strongly Undervalued below -0.91, Undervalued between -0.91 and 0.41, Fairly Valued between 3.04 and 0.41, Overvalued between 3.04 and 4.35, and Strongly Overvalued above 4.35. The current Forward PS of 0.05 falls within the Undervalued range.
0.00
P/OCF
Prophase Labs Inc. (PRPH) has a current P/OCF of 0.00. The 5-year average P/OCF is -6.44. The thresholds are as follows: Strongly Undervalued below -38.26, Undervalued between -38.26 and -22.35, Fairly Valued between 9.47 and -22.35, Overvalued between 9.47 and 25.38, and Strongly Overvalued above 25.38. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Prophase Labs Inc. (PRPH) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Prophase Labs Inc (PRPH) has a current Price-to-Book (P/B) ratio of 0.22. Compared to its 3-year average P/B ratio of 1.46 , the current P/B ratio is approximately -84.96% higher. Relative to its 5-year average P/B ratio of 2.10, the current P/B ratio is about -89.55% higher. Prophase Labs Inc (PRPH) has a Forward Free Cash Flow (FCF) yield of approximately -637.34%. Compared to its 3-year average FCF yield of -53.71%, the current FCF yield is approximately 1086.67% lower. Relative to its 5-year average FCF yield of -34.53% , the current FCF yield is about 1745.59% lower.
0.22
P/B
Median3y
1.46
Median5y
2.10
-637.34
FCF Yield
Median3y
-53.71
Median5y
-34.53
Competitors Valuation Multiple
The average P/S ratio for PRPH's competitors is 0.03, providing a benchmark for relative valuation. Prophase Labs Inc Corp (PRPH) exhibits a P/S ratio of 0.05, which is 79.25% above the industry average. Given its robust revenue growth of -37.64%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of PRPH decreased by 86.23% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -350.64 to -774.52.
The secondary factor is the Revenue Growth, contributed -37.64%to the performance.
Overall, the performance of PRPH in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
PHGE
Biomx Inc
2.2USD
-0.90%
MDRR
Medalist Diversified Reit Inc
12.31USD
-0.12%
BOF
BranchOut Food Inc
3.1701USD
1.93%
GXAI
Gaxos.ai Inc.
1.2USD
1.69%
EDUC
Educational Development Corp
1.37USD
0.00%
AQMS
Aqua Metals Inc
5.64USD
0.00%
LOBO
Lobo Technologies Ltd
0.6564USD
3.96%
TKLF
Tokyo Lifestyle Co Ltd
3.14USD
0.00%
DPRO
Draganfly Inc
8.65USD
1.65%
Frequently Asked Questions
Is Prophase Labs Inc (PRPH) currently overvalued or undervalued?
Prophase Labs Inc (PRPH) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.05 is considered Undervalued compared with the five-year average of 6.56. The fair price of Prophase Labs Inc (PRPH) is between 1.25 to 9.17 according to relative valuation methord. Compared to the current price of 0.20 USD , Prophase Labs Inc is Undervalued By 83.96% .
What is Prophase Labs Inc (PRPH) fair value?
PRPH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Prophase Labs Inc (PRPH) is between 1.25 to 9.17 according to relative valuation methord.
How does PRPH's valuation metrics compare to the industry average?
The average P/S ratio for PRPH's competitors is 0.03, providing a benchmark for relative valuation. Prophase Labs Inc Corp (PRPH) exhibits a P/S ratio of 0.05, which is 79.25% above the industry average. Given its robust revenue growth of -37.64%, this premium appears unsustainable.
What is the current P/B ratio for Prophase Labs Inc (PRPH) as of Jan 07 2026?
As of Jan 07 2026, Prophase Labs Inc (PRPH) has a P/B ratio of 0.22. This indicates that the market values PRPH at 0.22 times its book value.
What is the current FCF Yield for Prophase Labs Inc (PRPH) as of Jan 07 2026?
As of Jan 07 2026, Prophase Labs Inc (PRPH) has a FCF Yield of -637.34%. This means that for every dollar of Prophase Labs Inc’s market capitalization, the company generates -637.34 cents in free cash flow.
What is the current Forward P/E ratio for Prophase Labs Inc (PRPH) as of Jan 07 2026?
As of Jan 07 2026, Prophase Labs Inc (PRPH) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of Prophase Labs Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Prophase Labs Inc (PRPH) as of Jan 07 2026?
As of Jan 07 2026, Prophase Labs Inc (PRPH) has a Forward P/S ratio of 0.05. This means the market is valuing PRPH at $0.05 for every dollar of expected revenue over the next 12 months.